InvestorsHub Logo
Followers 2
Posts 849
Boards Moderated 1
Alias Born 08/24/2023

Re: None

Wednesday, 03/20/2024 6:48:38 PM

Wednesday, March 20, 2024 6:48:38 PM

Post# of 82
Yesterday, XRTX.v highlighted its important 2023 milestones, like receiving special designation from the FDA for its kidney disease treatment & getting closer to receiving accelerated approval. XRTX plans to keep up this momentum in 2024, conducting advanced clinical trials & working through regulatory processes.
https://www.xortx.com/news/press-releases/detail/151/xortx-highlights-achievements-of-2023-and-preparation-for
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XRTX News